International Biotechnology Trust’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

International Biotechnology Trust’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-18,250	Closed	-$596K	–	63
2018 Q4	$596K	Hold	18,250	–	–	0.37%	39
2018 Q3	$673K	Hold	18,250	–	–	0.32%	47
2018 Q2	$860K	Hold	18,250	–	–	0.33%	51
2018 Q1	$1.09M	Hold	18,250	–	–	0.43%	49
2017 Q4	$956K	Buy	+18,250	New	+$1.09M	0.34%	54

Other funds holding FSTX

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

International Biotechnology Trust's FSTX Position: Q1 2019 in Review

International Biotechnology Trust sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2019, closing a stake of 18,250 shares — an estimated $596K sold.

International Biotechnology Trust first reported a position in FSTX in Q4 2017 and held it in 5 quarters. The position peaked at $1.09M in Q1 2018. 54 funds tracked by Wall St. Rank hold FSTX as of Q1 2019.

International Biotechnology Trust reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
International Biotechnology Trust sold 18,250 F-star Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $596K.
International Biotechnology Trust first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2017 and held it in 5 quarters.
International Biotechnology Trust's F-star Therapeutics, Inc. Common Stock position peaked at $1.09M in Q1 2018.
54 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2019.

Based on International Biotechnology Trust's 13F filing for Q1 2019, filed 14 May 2019.